RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 127 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $9 | -72.7% | 5,880 | -74.0% | 0.00% | – |
Q4 2023 | $33 | +26.9% | 22,646 | -7.2% | 0.00% | – |
Q3 2023 | $26 | -16.1% | 24,396 | 0.0% | 0.00% | – |
Q2 2023 | $31 | -3.1% | 24,396 | +1.9% | 0.00% | – |
Q1 2023 | $32 | -22.0% | 23,937 | -13.1% | 0.00% | – |
Q4 2022 | $41 | -99.9% | 27,557 | 0.0% | 0.00% | – |
Q3 2022 | $33,000 | +6.5% | 27,557 | +1.6% | 0.00% | – |
Q2 2022 | $31,000 | -62.7% | 27,116 | -2.5% | 0.00% | -100.0% |
Q1 2022 | $83,000 | -48.1% | 27,816 | -53.9% | 0.00% | 0.0% |
Q4 2021 | $160,000 | +44.1% | 60,330 | +97.1% | 0.00% | 0.0% |
Q3 2021 | $111,000 | -20.7% | 30,608 | -5.1% | 0.00% | 0.0% |
Q2 2021 | $140,000 | +55.6% | 32,265 | +22.4% | 0.00% | -66.7% |
Q1 2021 | $90,000 | -2.2% | 26,364 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $92,000 | +46.0% | 26,364 | +0.3% | 0.00% | 0.0% |
Q3 2020 | $63,000 | +28.6% | 26,275 | -2.2% | 0.00% | +50.0% |
Q2 2020 | $49,000 | +6.5% | 26,878 | -9.1% | 0.00% | +100.0% |
Q1 2020 | $46,000 | -28.1% | 29,574 | -0.4% | 0.00% | 0.0% |
Q4 2019 | $64,000 | +16.4% | 29,707 | +0.8% | 0.00% | 0.0% |
Q3 2019 | $55,000 | -29.5% | 29,468 | -0.8% | 0.00% | -50.0% |
Q2 2019 | $78,000 | +18.2% | 29,714 | +16.2% | 0.00% | 0.0% |
Q1 2019 | $66,000 | +15.8% | 25,571 | +3.6% | 0.00% | 0.0% |
Q4 2018 | $57,000 | +62.9% | 24,692 | +128.4% | 0.00% | +100.0% |
Q3 2018 | $35,000 | -50.0% | 10,809 | -56.4% | 0.00% | -50.0% |
Q2 2018 | $70,000 | 0.0% | 24,790 | +26.1% | 0.00% | 0.0% |
Q1 2018 | $70,000 | -10.3% | 19,659 | -2.2% | 0.00% | 0.0% |
Q4 2017 | $78,000 | +90.2% | 20,098 | +25.4% | 0.00% | +100.0% |
Q3 2017 | $41,000 | +2.5% | 16,029 | +8.7% | 0.00% | 0.0% |
Q2 2017 | $40,000 | -14.9% | 14,747 | +3.0% | 0.00% | -50.0% |
Q1 2017 | $47,000 | +62.1% | 14,316 | +16.2% | 0.00% | +100.0% |
Q4 2016 | $29,000 | – | 12,325 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CM Management, LLC | 1,500,000 | $1,620,000 | 1.72% |
Soleus Capital Management, L.P. | 14,803,015 | $15,987,256 | 1.48% |
ARMISTICE CAPITAL, LLC | 17,136,000 | $18,506,880 | 0.28% |
SPHERA FUNDS MANAGEMENT LTD. | 1,228,126 | $1,326,376 | 0.24% |
GSA CAPITAL PARTNERS LLP | 971,441 | $1,049 | 0.09% |
NJ State Employees Deferred Compensation Plan | 200,000 | $216,000 | 0.03% |
Providence Wealth Advisors, LLC | 27,500 | $29,013 | 0.03% |
XTX Topco Ltd | 164,238 | $177,377 | 0.03% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 3,369,076 | $3,638,602 | 0.02% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,151,765 | $1,243,906 | 0.02% |